Mette Skov Holm
Mette Skov Holm publishes mostly in Hematology, Genetics and Molecular Biology, on topics such as Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research and Myeloproliferative Neoplasms: Diagnosis and Treatment.
- World rank
- #1,962,139 of 7,710,434 ranked researchers
- Rank in Denmark
- #14,858 of 43,819
- Works
- 57
- Citations
- 1.7k
- Citations per work
- 29.7
What does Mette Skov Holm research?
Mette Skov Holm's work is mostly in Medicine (65%), Biochemistry, Genetics and Molecular Biology (11%), Immunology and Microbiology (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3765.0%
- Medicine3765.0%
- Everything else1120.0%
- Life Sciences915.0%
- 1Hematology35% of their works
- 2Genetics18% of their works
- 3Molecular Biology11% of their works
- 4Public Health, Environmental and Occupational Health8% of their works
- 5Pathology and Forensic Medicine5% of their works
- 6Immunology4% of their works
Research topics
- Acute Myeloid Leukemia Research
- Acute Lymphoblastic Leukemia research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hemoglobinopathies and Related Disorders
- Chronic Lymphocytic Leukemia Research
- Epigenetics and DNA Methylation
- Hematological disorders and diagnostics
- Lymphoma Diagnosis and Treatment
Which keywords describe Mette Skov Holm's research?
The keywords of their largest research topics: Prognostic Factors, Acute Myeloid Leukemia, AML, Rituximab, Acute Lymphoblastic Leukemia, Childhood Cancer, JAK2 Mutation and Myelofibrosis.
- Lymphoma
- FDG PET/CT
- Classification
- Genomic Aberrations
- Thalassemia
- Myelofibrosis
- Childhood Cancer
- Rituximab
- AML
- Prognostic Factors
- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- JAK2 Mutation
- Sickle-cell Disease
- Chronic Lymphocytic Leukemia
- Bone Marrow Biopsy
- DNA Methylation
- Histone Modification
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 18 words, with their numbers
- Prognostic Factors643 topics
- AML451 topic
- Acute Myeloid Leukemia451 topic
- Rituximab132 topics
- Acute Lymphoblastic Leukemia121 topic
- Childhood Cancer121 topic
- JAK2 Mutation111 topic
- Myelofibrosis111 topic
- Sickle-cell Disease81 topic
- Thalassemia81 topic
- Chronic Lymphocytic Leukemia71 topic
- Genomic Aberrations71 topic
- Bone Marrow Biopsy61 topic
- Classification61 topic
- DNA Methylation61 topic
- FDG PET/CT61 topic
- Histone Modification61 topic
- Lymphoma61 topic
Where does Mette Skov Holm work?
Mette Skov Holm's main affiliation in the publication record is Aarhus University Hospital, Denmark.
How many publications and citations does Mette Skov Holm have?
OpenAlex counts 57 works and 1,694 citations for Mette Skov Holm, an h-index of 20, ranking #1,962,139 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Mette Skov Holm. Posts are plain text and can be reported.